MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmjno-2026-001670

Медицинская библиотека · BMJ neurology open · 2026

Slowing the curve: a single-arm meta-analysis of mFARS outcomes following omaveloxolone treatment in Friedreich ataxia.

Ali Aasim, Cheema Waqar Ahmed, Nisar Fiza, Reyaz Ufaq, Saad Muhammad, Talha Muhammad, Sarfraz Sameen, Butt Ahmad, Shamoon Muhammad, Abdullah Armaghana, Shabbir Muhammad Asad, Talha Muhammad, Azam Hammad, Abdullah Muhammad, Anwaar Aimen

СтатьяОбзорПеревод в очереди

Аннотация

Friedreich ataxia (FRDA) is a progressive neurodegenerative disorder with limited treatments. Omaveloxolone, an Nrf2 activator, was approved based on a phase III trial showing modified Friedreich Ataxia Rating Scale (mFARS) improvement. Real-world and long-term data now require synthesis. To perform a single-arm meta-analysis pooling mean change in mFARS from baseline across all published omaveloxolone studies and interpret findings against natural history. Four studies (MOXIe Part 1, Part 2, open-label extension, Italian observational) comprising 248 patients were included. Data were harmonised using standard conversions. A random-effects model was used with subgroup and sensitivity analyses. The pooled mean ΔmFARS was -0.05 (95% CI -2.98 to 2.88; p=0.97). Subgroup analysis showed significant improvement in controlled trials (-2.19; 95% CI -3.12 to -1.27; p<0.00001) and consistent progression in real-world studies (+2.85; 95% CI 1.62 to 4.08; p<0.00001). Sensitivity analyses confirmed robustness. Controlled trials demonstrate significant short-term improvement with omaveloxolone, while real-world data show consistent progression at rates substantially slower than natural history. These complementary findings support a disease-modifying effect of omaveloxolone in FRDA.

Для цитирования: Ali Aasim, Cheema Waqar Ahmed, Nisar Fiza, Reyaz Ufaq, Saad Muhammad, Talha Muhammad, Sarfraz Sameen, Butt Ahmad, Shamoon Muhammad, Abdullah Armaghana, Shabbir Muhammad Asad, Talha Muhammad, Azam Hammad, Abdullah Muhammad, Anwaar Aimen. Slowing the curve: a single-arm meta-analysis of mFARS outcomes following omaveloxolone treatment in Friedreich ataxia.. BMJ neurology open. 2026. DOI: 10.1136/bmjno-2026-001670.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.